# Biomatics Capital: portfolio, investments and team > Biomatics Capital is a vc firm based in United States. 12 investments on record, latest Nov 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/biomatics-capital (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Biomatics Capital Last cheque observed Nov 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Quiet New fund $200M, May 2018 VC firm Seed Series A Series B Diagnostics Ivd Bioimaging Follow Biomatics Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fbiomatics-capital) Cheques on record **0%** of best year **0** **cheques in 12 months**, 12 on record Since the last cheque **2550** days **00** hrs **00** min **00** sec Median round **$48M** Cheque size, as they say **$5.0M – $20M** Rounds led **0 of 12** Sole investor **1 rounds** Mostly in **United States, 100%** Pitch Biomatics Capital ## Biomatics Capital highlights - 01 12 rounds on record - 02 Mostly Series A and Series B: 91% of its rounds - 03 Sole investor in 1 rounds, median $20M ## What they do > Biomatics Capital is a for-profit venture firm investing in transformational data enabled innovation at the intersection of health care and technology. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** $5.0M – $20M as they say - **Stages:** Seed Series A Series B Growth - **Sectors:** Diagnostics Ivd Bioimaging - **Based in:** Seattle, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **12 appearances** - **2019** 5 rounds - **Nov** **[AiCure](https://millionrounds.com/company/aicure)** Series C · US · FinSMEs **$25M** With 10 others - **Nov** **[eGenesis](https://millionrounds.com/company/egenesis)** Series B · US · FinSMEs **$100M** With 6 others - **Jun** **[Blackthorn Therapeutics](https://millionrounds.com/company/blackthorn-therapeutics)** Series B · US · FinSMEs **$76M** With 11 others - **May** **[Thrive](https://millionrounds.com/company/thrive)** Series A · US · FinSMEs **$110M** With 9 others - **May** **[Verve Therapeutics](https://millionrounds.com/company/verve-therapeutics)** Series A · US · FinSMEs **$59M** With 3 others - **2018** 4 rounds - **Oct** **[Aledade](https://millionrounds.com/company/aledade)** US · Axios **$23M** With 1 other - **Jul** **[Omniome](https://millionrounds.com/company/omniome)** Series B · US · FinSMEs **$60M** With 6 others - **Jul** **[Compass Therapeutics](https://millionrounds.com/company/compass-therapeutics)** Series A · US · FinSMEs **$132M** With 7 others - **Jun** **[Cytrellis](https://millionrounds.com/company/cytrellis)** Series B · US · FinSMEs **$29M** With 3 others - **2017** 3 rounds - **Mar** **[eGenesis](https://millionrounds.com/company/egenesis)** Series A · US · FinSMEs **$38M** With 7 others - **Jan** **[Aledade](https://millionrounds.com/company/aledade)** Series B · US · FinSMEs **$20M** Sole investor - **Jan** **[BlackThorn Therapeutics](https://millionrounds.com/company/blackthorn-therapeutics)** Series A · US · FinSMEs **$14M** With 1 other An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **2 named** BN **Boris Nikolic** Managing Member of the General Partner i Filing they signed JE **Julie Estelle Sunderland** Managing Member of the General Partner i Filing they signed We also hold **2** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$141M** gross assets of its funds Oct 2026 **Exempt** reporting adviser venture or small private funds - **Legal name:** Biomatics Management Company, LLC - **SEC number:** CRD 284637 New fund on file **$200M** raised in May 2018 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$48M** the round, not its cheque Alone, median **$20M** Led 0 of 12 rounds **0%** - **Said size:** $5.0M – $20M - **Sole investor:** 1 rounds - **Last cheque:** Nov 2019 Rounds by stage said on their site - Series A said *5* - Series B said *5* - Series C *1* - Seed said *-* - Growth said *-* Cheques by year Led Joined 2017 2019 Often in the room with - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 3 - [Arch](https://millionrounds.com/fund/arch) 3 - [Google Ventures](https://millionrounds.com/fund/gv) 3 - [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 2 - [Altitude Life Science Ventures](https://millionrounds.com/fund/altitude-life-science-ventures) 2 **Pitching Biomatics Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Biomatics Capital. A count of rooms they were both in, not a relationship either has claimed. [**Alexandria Real Estate Equities** VC firm **3** rounds together](https://millionrounds.com/fund/alexandria)[**Arch** Hedge fund **3** rounds together](https://millionrounds.com/fund/arch)[**Google Ventures** Corporate VC **3** rounds together](https://millionrounds.com/fund/gv)[**ARCH Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Altitude Life Science Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/altitude-life-science-ventures) ## Recently backed The latest companies Biomatics Capital put money into. [**AiCure** $25M · Nov 2019](https://millionrounds.com/company/aicure)[**Blackthorn Therapeutics** $76M · Jun 2019](https://millionrounds.com/company/blackthorn-therapeutics)[**Verve Therapeutics** $59M · May 2019](https://millionrounds.com/company/verve-therapeutics)[**Aledade** $23M · Oct 2018](https://millionrounds.com/company/aledade)[**Compass Therapeutics** $132M · Jul 2018](https://millionrounds.com/company/compass-therapeutics) ## Quick answers about Biomatics Capital ### What does Biomatics Capital invest in? Biomatics Capital invests most often at Series A and Series B (91% of the rounds on record), in sectors such as Diagnostics, Ivd and Bioimaging. ### How active is Biomatics Capital? 12 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2019. ### What has Biomatics Capital invested in recently? Its most recent investments on record: AiCure (Series C, Nov 2019), eGenesis (Series B, Nov 2019) and Blackthorn Therapeutics (Series B, Jun 2019). ### How big are Biomatics Capital's cheques? The median round it joins is $48M. It says it writes cheques of $5.0M to $20M. ### Does Biomatics Capital lead rounds? Rarely, if at all: none of its 12 investments on record names it as the lead. ### Where does Biomatics Capital invest? Most of the companies it backs are in the United States (100%). ### Is Biomatics Capital investing now? No investments in the last 12 months; the latest was in Nov 2019. ### Who does Biomatics Capital invest alongside? Most often Alexandria Real Estate Equities (3 rounds together), Arch (3 rounds together) and Google Ventures (3 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=biomatics-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=biomatics-capital)